Trial
NCT01074502
Apremilast in the Treatment of Moderate to Severe Acne
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of North Carolina, Chapel Hill
Collaborators
Celgene
Condition
Acne
Intervention
apremilast
Why stopped
lack of funding due to Celgene administrative decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-03-13